Maxigen Biotech Inc
TWSE:1783

Watchlist Manager
Maxigen Biotech Inc Logo
Maxigen Biotech Inc
TWSE:1783
Watchlist
Price: 46.9 TWD Market Closed
Market Cap: 4.2B TWD
Have any thoughts about
Maxigen Biotech Inc?
Write Note

Operating Margin
Maxigen Biotech Inc

23.9%
Current
21%
Average
5.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
23.9%
=
Operating Profit
149.1m
/
Revenue
623.8m

Operating Margin Across Competitors

Country TW
Market Cap 4.2B TWD
Operating Margin
24%
Country FR
Market Cap 181.7B EUR
Operating Margin
19%
Country UK
Market Cap 114.1B GBP
Operating Margin
18%
Country IN
Market Cap 5.5T INR
Operating Margin
22%
Country UK
Market Cap 34.9B GBP
Operating Margin
19%
Country DE
Market Cap 27.8B EUR
Operating Margin
11%
Country US
Market Cap 26.9B USD
Operating Margin
10%
Country JP
Market Cap 3T JPY
Operating Margin
7%
Country IN
Market Cap 1.1T INR
Operating Margin
21%
Country IN
Market Cap 895.9B INR
Operating Margin
15%
Country US
Market Cap 9.9B USD
Operating Margin
19%
No Stocks Found

Maxigen Biotech Inc
Glance View

Market Cap
4.2B TWD
Industry
Consumer products

Maxigen Biotech, Inc. engages in the research, development, manufacturing, and sales of biomedical materials and beauty care products. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2011-05-18. The firm operates through two main segments. The Consumer Products segment is mainly engaged in the wholesales of cleansing products, facial care products, medical beauty products and others. The Biomedical Products is mainly involved in the manufacture and sales of Formagraft collagen and ceramic composite material products, Foramic ceramic bone feed materials, Artiaid hyaluronic acid joint injection products, ViscAid ophthalmology viscoelastic agents, as well as SurgiAid wound collagen materials and others.

Intrinsic Value
30.4 TWD
Overvaluation 35%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
23.9%
=
Operating Profit
149.1m
/
Revenue
623.8m
What is the Operating Margin of Maxigen Biotech Inc?

Based on Maxigen Biotech Inc's most recent financial statements, the company has Operating Margin of 23.9%.